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Abstract
Objective—To test the hypotheses that: 1) the transient receptor potential vanilloid 4 (TRPV4)
ion channel is protective in the obesity-model of osteoarthritis (OA), resulting in more severe
obesity-induced OA in Trpv4 knockout (Trpv4−/−) mice; and 2) loss of TRPV4 alters mesodermal
stem cell differentiation.
Methods—Male Trpv4−/− and wild-type (Trpv4+/+)mice were fed a control or high-fat diet (10%
kcal and 60% kcal from fat, respectively) for 22 weeks, at which time spontaneous cage activity
and severity of knee OA were evaluated. In addition, the adipogenic, osteogenic, and
chondrogenic potential of bone marrow-derived (MSC) and adipose-derived (ASC) stem cells
from Trpv4−/− and Trpv4+/+ mice were compared.
Results—A high-fat diet significantly increased knee OA scores and reduced spontaneous cage
activity in Trpv4−/− mice, while also increasing weight gain and adiposity. MSCs from Trpv4−/−
mice had decreased adipogenic and osteogenic differentiation potential versus Trpv4+/+ MSCs.
ASCs from Trpv4−/− mice had increased adipogenic and osteogenic and reduced chondrogenic
differentiation potential versus Trpv4+/+ ASCs.
Conclusion—Pan-Trpv4−/− mice develop more severe OA with high-fat feeding, potentially due
to more severe diet-induced obesity. The altered differentiation potential of Trpv4−/− progenitor
cells may reflect the importance of this ion channel in the maintenance and turnover of
mesodermally-derived tissues.
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Obesity is one of the most significant and modifiable risk factors for osteoarthritis (OA).[1]
However, local biomechanical factors associated with changes in the onset and progression
of knee OA in the obese population[2,3] cannot explain the relationship between obesity and
OA in non-load bearing joints.[4] Obesity and related metabolic syndromes are associated
with chronic low-grade inflammation and systemic tissue damage.[5] Recent studies suggest
that these systemic metabolic factors participate in the development of OA in both weight
bearing and non-weight bearing joints;[6] however, the mechanisms by which these
systemic factors alter the course of OA remain unclear.[7]
The transient receptor potential vanilloid 4 (TRPV4) ion channel is a Ca2+-preferred cation
channel, originally characterized as a transducer of osmotic stress.[8,9] TRPV4-mediated
Ca2+ signaling in response to osmotic fluctuations in the cartilage is one potential
mechanism by which chondrocytes sense and respond to joint loading.[10] Recent findings
indicate that TRPV4 signaling plays a crucial role in skeletal development[11,12], while
genetically-encoded deletion of TRPV4 in mice leads to accelerated joint degeneration with
aging.[13] More recent findings also suggest that chondrocyte TRPV4 could be a multi-
modally modulated channel, interacting with pro-inflammatory mediators and cytokines to
mediate catabolic signaling and nociception.[14,15]
We hypothesized that the absence of TRPV4-mediated signaling in the presence of the
catabolic, biomechanical and inflammatory factors of obesity would accelerate OA
progression in the high-fat diet model of OA. To examine the link between the observed
phenotype of Trpv4−/− mice and function of TRPV4 at the cellular level, we measured the
effects of TRPV4 deficiency on the intrinsic capabilities of bone marrow-derived (MSCs)
and adipose-derived (ASCs) stem cells, isolated from Trpv4−/− and Trpv4+/+ mice, to
differentiate towards the adipogenic, osteogenic, and chondrogenic lineages.
MATERIALS AND METHODS
Detailed methods are available as supplementary material (available online only).
Animal Handling
At 10 weeks of age, male pan-Trpv4 knockout (Trpv4−/−) and wild-type (Trpv4+/+) mice
were placed on either a high-fat (60% kcal) or control diet (10% kcal) for 22 weeks, at
which time, spontaneous locomotor activity was measured.
Body Composition
Immediately following sacrifice, total body fat of each mouse was measured using Dual
Energy X-ray absorptiometry.[6]
Histologic Evaluation of OA
Sections of hind limb joints were stained with Hematoxylin, Safranin-O and Fast Green and
scored for degenerative changes using a modified Mankin system by three blinded graders.
[16] Sections of subcutaneous fat tissue from 10-week old Trpv4−/− and Trpv4+/+ mice were
also taken and stained with Hematoxylin and Eosin.
Stem Cell Isolation, Purification, and Expansion
Bone marrow derived stem cells (MSC) and subcutaneous adipose-derived stem cells (ASC)
were isolated from the femurs and tibias (MSC), and the inguinal fat pad (ASC) of Trpv4−/−
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and Trpv4+/+ mice (8–10 weeks old), using a recently described method involving FACS to
obtain cells with specific cell markers, [17,18] and expanded to P3.
Tridifferentiation
Passage 3 MSCs and ASCs were induced towards the adipogenic, osteogenic, or
chondrogenic lineages and assayed for differentiation capacity. Adipogenesis was quantified
by Oil-Red-O release, while osteogenesis was quantified by Alizarin stain release.
Chondrogenic differentiation was assessed by Alcian blue staining and glycosaminoglycan
content.
Statistical Analysis
Normality was tested, and data were log-transformed before analysis if necessary. Statistical
analysis was performed using multiple-factor analysis of variance (ANOVA) for comparison
of multiple groups, with Fisher LSD post-hoc analysis using α=0.05. Significant differences
were reported at the 95% confidence interval unless otherwise noted. Data are presented as
mean±standard error of the mean.
RESULTS
Trpv4−/− mice are more susceptible to diet-induced obesity than Trpv4+/+ mice
Trpv4−/− mice weighed significantly more than Trpv4+/+ mice at 10 weeks of age (Fig. 1A,
B). After being fed a high-fat diet, Trpv4−/− mice gained significantly more weight than
Trpv4+/+ mice (Fig. 1A, B). DXA measurements after high-fat feeding revealed that the
differences in body mass with genotype and diet were due to body fat, with Trpv4−/− mice
gaining significantly more body fat than Trpv4+/+ mice following high-fat feeding (Fig. 1C).
To further examine the obese phenotype of Trpv4−/− mice, histological sections were taken
of the inguinal fat pad of 10-week old normally fed mice and showed that even prior to high-
fat feeding, Trpv4−/− mice may possess larger adipocytes than Trpv4+/+ controls (Fig. 1D).
High-fat fed Trpv4−/− mice have lower cage activity than high-fat fed Trpv4+/+ mice
To further investigate the relationship between Trpv4 deficiency and increased weight gain,
spontaneous cage activity was measured after three days of habituation. For mice fed a
control fat diet, genotype had no effect on dark cycle locomotor activity (p=0.332); yet,
when fed a high-fat diet, Trpv4−/− mice were 40% as active as Trpv4+/+ mice (Fig. 1E).
Trpv4 deficiency increases knee osteoarthritis following high-fat feeding
A modified Mankin score was tabulated and analyzed that combined the score for cartilage
structural degeneration and proteoglycan loss as recommended in reference[19]. Neither
Trpv4−/− nor high-fat feeding alone increased joint degeneration; however, the combination
of the two factors increased OA severity (Fig. 2A, B). Trpv4−/− mice also demonstrated
altered chondrocyte histomorphology, with reduced chondrocyte cloning and chondrocyte
hypertrophy (Fig. 2C, Fig. S1 available online).
Altered in vitro differentiation of Trpv4−/− progenitor cells
MSCs and ASCs were isolated from 10-week old Trpv4−/− and Trpv4+/+ mice and expanded
to P3. No effect of genotype on expansion rate was observed (Fig. 3A1). Trpv4−/− MSCs
exhibited a reduced adipogenic differentiation potential compared to MSCs isolated from
Trpv4+/+ mice, whereas Trpv4−/− ASCs demonstrated a largely increased adipogenic
differentiation potential compared to Trpv4+/+ ASCs (Fig. 3A2, 3B). Similarly, Trpv4−/−
MSCs demonstrated a reduced osteogenic differentiation potential while Trpv4−/− ASCs had
an increased osteogenic differentiation potential (Fig. 3A3, 3C). No effect of Trpv4
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deficiency was observed with MSC chondrogenic differentiation. However, Trpv4−/−ASCs
demonstrated a reduced chondrogenic differentiation potential compared to Trpv4+/+ ASCs,
as indicated by less GAG/DNA (Fig. 3D) and Alcian Blue staining (Fig 3A4).
DISCUSSION
Our findings indicate that TRPV4 exhibits a chondroprotective role in diet-induced OA.
Trpv4−/− mice exhibited an increased susceptibility to high fat diet-induced OA, potentially
due in part to an increased susceptibility to diet-induced obesity. MSCs and ASCs from
these mice also demonstrated altered differentiation potential, with ASCs from Trpv4−/−
mice exhibiting significantly higher adipogenic potential and decreased chondrogenic
potential.
Our observations that very high-fat fed Trpv4−/− mice are particularly prone to obesity
stands in contrast with the findings by Kusodu et al. that pan-Trpv4−/− mice are protected
from diet-induced obesity.[20] However, substantial differences exist between these two
studies regarding, including age at diet initiation, composition, and duration of high-fat
feeding. In this study, mice were fed a 60% high-fat diet for 22 weeks beginning at 10
weeks, compared to a 42% kcal diet beginning at 16 weeks and lasting 12 weeks in [20]. In
addition, although we did not measure food consumption or energy expenditure in our study
(no effect of Trpv4 knockout was found in [20]), we observed reduced cage activity of high-
fat fed Trpv4−/− mice. It is unclear, however, whether this represent a cause and/or a
consequence of the additional weight gain of Trpv4−/− mice. Additionally, given the
chondroprotective effect of activity in the setting of diet-induced obesity, [21] it is even
possible that this decrease in activity increased the severity of joint degeneration in the
Trpv4−/− mice directly.
While neither high-fat feeding nor Trpv4 deficiency alone increased OA severity at 8
months of age, a combination of these two factors did. This finding is generally consistent
with previous work showing that Trpv4−/− mice exhibit significant spontaneous OA changes
at 9 months.[13] Similarly, high-fat diet feeding alone did not produce a significant increase
in OA, but is consistent with previous similarly designed studies. Though this study supports
the hypothesis that TRPV4 plays a role in the pathogenesis of obesity-associated OA, further
investigation is needed to fully describe the cartilage-specific role of TRPV4 in obesity and
OA.
Trpv4−/− mice at 32 weeks of age exhibited a chondrocyte morphology that is distinct from
that of Trpv4+/+ mice, with less chondrocyte cloning and hypertrophy observed in the
articular cartilage of Trpv4−/− mice. The cause of chondrocyte cloning (or chondrocyte
cluster formation) in osteoarthritic cartilage and its influence on cartilage disease
progression is unknown, but may signify a proliferative repair response.[22] Chondrocyte
hypertrophy in articular cartilage also signifies altered metabolic activity by chondrocytes
following tissue damage and inflammation.[23,24] Further studies will be needed to
determine if TRPV4 mediates these or other chondrocyte responses to joint insult.
We observed an altered metabolic and osteoarthritic response of Trpv4−/− mice to high-fat
feeding. In an attempt to better understand the role of this channel in these mesodermally-
derived tissues, we examined whether adult stem cells would also exhibit altered growth or
differentiation characteristics in vitro that reflect the tissue characteristics observed in vivo.
Isolated MSCs from Trpv4−/− mice exhibited reduced adipogenesis, while ASCs revealed
significantly increased adipogenesis. Consistent with these in vitro findings, adipocytes in
Trpv4−/− mice appeared larger than those of Trpv4+/+ mice at 10 weeks of age. Determining
the role of TRPV4 in adipose tissue function, as is being actively pursued with other TRP
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channels, [25] could yield important insight into both metabolic and inflammatory-
associated diseases.
The role of TRPV4 in bone metabolism is also evident in Trpv4−/− mice, which display
increased bone volume that may in fact contribute to increased cartilage degeneration
directly.[13] While the skeletal phenotype of Trpv4−/− mice has been largely attributed to
impaired osteoclast function, [26] we found that Trpv4−/− MSCs exhibited reduced
osteogenesis, while Trpv4−/− ASCs exhibited increased osteogenesis. Future investigations
are needed to fully deconstruct the role of TRPV4 in bone development, remodeling, and
repair.
Though we found no effect of TRPV4 in MSC chondrogenesis, it is plausible that the potent
application of growth factors required to induce in vitro chondrogenesis (TGF-β3, BMP-6)
may have overpowered the effect of basal TRPV4 signaling in these cells. TRPV4 activation
in chondroprogenitors has been shown to enhance Sox9 expression in a Ca2+-dependent
manner, one of the main regulators of cartilage-specific expression of matrix molecules such
as collagen type II and aggrecan.[27] Interestingly, we observed that chondrogenesis was
diminished in Trpv4−/− ASC, possibly due to the altered phenotype and metabolism of the
pan-Trpv4−/− adipose tissue, rather than indicating a direct effect of loss of TRPV4 signaling
with chondrogenic differentiation. Further studies are necessary to establish the role of
TRPV4 in adipose tissue that led to the pro-obesity phenotype in our Trpv4−/− mice.
In conclusion, global loss of Trpv4 increases knee OA severity in response to high-fat
feeding in a manner that is associated with increased weight gain. However, the effects of
pan-Trpv4 deletion, such alterations in bone remodeling, [13,26] and energy metabolism,
complicates conclusions regarding the in vivo role of various progenitor cells in this model
system. There may be other systemic effects of pan-Trpv4 knockout as well, included
altered nociception, given the involvement of TRPV4 in joint inflammation and pain.[15,28]
Use of tissue-targeted Cre-lox systems[29–31] may help to define the tissue-specific effects
of TRPV4 signaling with respect to obesity, joint inflammation, pain, and OA. Determining
the cartilage-specific role of TRPV4 in the many etiologies and models of OA, including
obesity-induced OA, should provide new insight into molecular mechanisms that link
biomechanical and inflammatory factors of OA, hopefully leading to new preventions and
treatments for this prevalent disease.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Trpv4−/− mice show increased adiposity in response to high-fat feeding
A. High-fat fed mice weighed significantly more than control diet mice by week 7. By week
10, knockout (KO) 60% mice weigh significantly more than all other groups (p=0.022) &
Trpv4 KO >WT (p<0.05), *60% diet >10% diet (p<0.05), ^60% KO >all other groups
(p<0.05), +60% KO >10% WT (p<0.05). B, Wild-type (WT) 60% mice gained
(insignificantly) more weight after 22 weeks of high-fat feeding compared to WT 10% mice
(p=0.0837), whereas KO 60% mice gained more weight than all other groups (p=0.003). C,
Post-diet, mice did not differ in the amount of lean body mass. WT 60% mice had
significantly more body fat than WT 10% mice, but KO 60% had more body fat than all
other groups (p<0.001). D, Histological sections of subcutaneous adipose tissue from 10-
week-old mice, with KO adipocytes appearing larger than WT adipocytes, Scale
bar=100μm. E, When fed a high-fat diet, Trpv4−/−mice were 40% as active during the dark
cycle as Trpv4+/+ mice (diet: p=0.833, genotype: p=0.003, genotype*diet: p=0.091). Data
are shown as mean ±SEM. Data not sharing a common superscript letter indicate a
significant difference (p<0.05).
O’Conor et al. Page 8










Figure 2. Trpv4−/− mice have more severe diet-induced osteoarthritis and altered chondrocyte
histomorphology
A. Representative histological images, scale bar = 500 μm. B. KO 60% mice have more
severe joint degeneration than WT 10% mice (genotype: p=0.057, diet: p=0.049,
genotype*diet: p=0.779). C. Trpv4−/− joints have less chondrocyte cloning and chondrocyte
hypertrophy (p<0.001). Data are shown as mean±SEM. Data not sharing a common
superscript letter indicate a significant difference (p<0.05).
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Figure 3. Adult stem cells from Trpv4−/− mice exhibit altered differentiation potential
MSCs and ASCs were purified and expanded as described previously (17,18). Data for
adipogensis and osteogenesis were normalized to DNA content and to the staining of cells
cultured in control media. A. 1. MSCs and ASC from Trpv4−/− mice expanded equally
rapidly in hypoxic culture. A2–4. A: WT MSC B: WT ASC C: KO MSC D: KO ASC. A2.
Cell morphology at day 7 of adipogenic differentiation. A3. Alizarin Red staining at day 14
osteogenesis. A4. Chondrogenically induced cell pellets (Alcian Blue/Nuclear Fast Red). B.
Bone marrow derived MSCs have a reduced ability to differentiate when cultured in
adipogenic media (p=0.008), while ASCs show a large increase (p<0.001). C. Bone marrow
derived MSCs have a reduced ability to differentiate when cultured in osteogenic media
(p<0.001), while ASCs show an increased ability (p<0.001). D. Trpv4 deficiency does not
affect in vitro MSC chondrogenesis. However, Trpv4−/− ASCs have decreased GAG
accumulation (p=0.036) and Alcian Blue staining. D. Data are shown as mean±SEM. *
indicates significant difference (p<0.05).
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